Study of Everolimus (RAD001) in Patients With Recurrent Glioblastoma Multiforme (GBM)
type: MedicalStudy
description: A Phase II Trial of RAD001 in Patients With Recurrent Glioblastoma Multiforme
status: TERMINATED
study design: INTERVENTIONAL
phase: PHASE2
start date: 2007-08
end date: 2009-08
license: https://creativecommons.org/publicdomain/zero/1.0/
source: https://clinicaltrials.gov/study/NCT00515086
source organization: US National Library of Medicine
publisher: AI Analytics
sponsor: Novartis Pharmaceuticals
study subject: Glioblastoma Multiforme
keywords: PHASE2
keywords: INTERVENTIONAL
keywords: TERMINATED
keywords: Glioblastoma Multiforme

AI Analytics
type: Organization